Skip to main content

Month: September 2021

Stitch Fix Announces Fourth Quarter and Full Fiscal Year 2021 Financial Results

SAN FRANCISCO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal shopping and styling service, has released its financial results for the fourth quarter and full fiscal year 2021 ended July 31, 2021. Stitch Fix CEO Elizabeth Spaulding said, “In Q4 we delivered $571 million in net revenue, reflecting 29% year-over-year growth, helping us cross $2 billion in annual net revenue for the first time. These results reflect strong performance across our business, in Women’s, Kids and the UK. Today, we are proud to serve almost 4.2 million clients, and with the launch of Stitch Fix Freestyle in August we are significantly increasing our addressable market and we’re energized by the opportunity ahead. As we look forward, we are focused on continuing to expand and transform our offering, and drive...

Continue reading

Brilliant Acquisition Corporation Announces Extension of Completion Window to December 25, 2021

New York, Sept. 21, 2021 (GLOBE NEWSWIRE) — Brilliant Acquisition Corporation (the “Company”) announced today that it has extended the period of time it will have to consummate its initial business combination by 3 months from the current deadline of September 25, 2021 until December 25, 2021 (the “completion window”) because the Company’s Sponsor, Nisun Investment Holding Limited has timely deposited $460,000 in the Company’s trust account, representing $0.10 per Unit as additional interest on the proceeds in the trust account, pursuant to the terms of the Company’s amended and restated memorandum and articles of association, and the trust agreement entered into between the Company and Continental Stock Transfer & Trust Company. About the Company Brilliant Acquisition Corporation is a blank check company organized for the...

Continue reading

Inventiva announces FDA decision that Fast Track designation granted to lanifibranor in NASH encompasses the treatment of NASH with compensated cirrhosis

The FDA decision follows the Company’s Fast Track designation request for lanifibranor in NASH with compensated cirrhosis filed in August 2021Daix (France), Long Island City (New York, United States), September 21, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has decided that the Fast Track designation previously granted to lanifibranor in NASH encompasses the treatment of NASH patients with compensated cirrhosis. This decision follows a Fast Track designation request for lanifibranor in NASH with compensated cirrhosis filed...

Continue reading

Selectis Health Announces Effective Date of Reverse Stock Split and Name Change

Common Stock Will Begin Trading with its new name and on a Split-Adjusted Basis on September 22, 2021 GREENWOOD VILLAGE, Colorado, Sept. 21, 2021 (GLOBE NEWSWIRE) — Selectis Health, Inc. (formerly Global Healthcare REIT, Inc.) (the “Company” or “Selectis”), announced today that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 10 pre-split share (the “Reverse Split”). Selectis’ common stock will continue to be traded on the OTC.Pink of the OTC Markets Group, Inc. under the ticker symbol GBCS and will begin trading on a split-adjusted basis when the market opens on Wednesday, September 22, 2021, (the “Effective Date”) under a new CUSIP number 816291108. For a period of 20 business days, a “D” will be placed on the Company’s ticker symbol to reflect the Reverse Split. Also on...

Continue reading

AllStar Health Shareholder Update

MIAMI, Sept. 21, 2021 (GLOBE NEWSWIRE) — AllStar Health Brands (OTC Pink: ALST) has opted to issue a shareholder update as there are a number of initiatives that are now coming to fruition. ALST has formed a strategic partnership with Virotek Biosciences Inc., to facilitate the application of the rapid COVID test to the various AllStar commercial, industrial and civic customers. Agreeing to regular testing appears to be one of the alternatives that some employers will accept in place of double dose vaccine. This opens the way for services such as the ALST- Virotek partnership to complete those tests. The Company has also entered into the testing phase of the new web site https://vividcbd.com/. We have secured a contracted supply of the product, we have the rights to expand into other product lines, and we have the systems in place...

Continue reading

Viper Networks Reduces Debt by $12.7 Million with Preferred Stock Debt Conversion

TROY, Mich., Sept. 21, 2021 (GLOBE NEWSWIRE) — Viper Networks, Inc. (OTC Pink: VPER), (Company), an emerging company in the LED lighting products and integrated systems markets, announced today that the Company has further reduced their total debt by $12,716,841 USD. The Company has been working diligently to improve financial performance and had announced a debt reduction of $38,567,237 million back in May. Furthering this effort, the Company has reached an agreement to reduce another $12,716,841 by negotiating accrued executive compensation and issuing 10,597,368 restricted shares of Series B Preferred stock, leaving a debt of approximately only $500,000 – a substantial 96 percent reduction netting over 99 percent debt reduction through the year. To date, we have had a very good year with a stock growth of over 1800%, a strategic...

Continue reading

RadNet, Inc. to Present at the Sidoti & Company Fall 2021 Virtual Conference on Thursday, September 23rd

LOS ANGELES, Sept. 21, 2021 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Sidoti & Company Fall 2021 Conference on Thursday, September 23rd at 4:00 p.m. Eastern Time. There will be simultaneous and archived webcasts available at https://sidoti.zoom.us/webinar/register/WN_ia_3NO7wT9eqX4hssKG6BQ and www.radnet.com under the “About RadNet” menu section and “News and Press Releases” sub-menu of the website.Details for RadNet’s Presentation:Date: Thursday, September 23, 2021Time: 4:00 p.m. Eastern TimeURL: https://sidoti.zoom.us/webinar/register/WN_ia_3NO7wT9eqX4hssKG6BQAbout...

Continue reading

Ayr Wellness Reminds Holders of the Previously Announced Incentive for Cash Exercise and Notice of Early Expiry of All Remaining Warrants

MIAMI, Sept. 21, 2021 (GLOBE NEWSWIRE) — Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“Ayr” or the “Company”), a leading vertically-integrated cannabis multi-state operator, would like to provide a reminder of the notice provided on August 31, 2021 (“August Press Release”) of the accelerated expiry of the Company’s share purchase warrants (the “Warrants”). As announced in the August Press Release, the expiry of the Warrants is being accelerated as permitted under the warrant agency agreement dated December 21, 2017 between the Company and Odyssey Trust Company, as warrant agent, as amended. As announced, the expiry date of the Warrants is 5:00 p.m. (Toronto time) on September 30, 2021 (the “Accelerated Warrant Expiry Date”). The Accelerated Warrant Expiry Date falls on National Day for Truth and Reconciliation, a Canadian national...

Continue reading

Proactive news headlines including Entain, Loncor, NexTech AR, Western Magnesium and ME2C Environmental

New York, Sept. 21, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:Entain confirms takeover offer from DraftKings, reported to be worth $20bn click here Loncor promotes VP of business development John Barker to CEOBioSig Technologies appoints medical-device industry executive James Barry as independent board director click here DGTL Holdings inks new $400k contract with Nasdaq listed online sports gaming client click here FSD Pharma closes its all-stock acquisition of Canada’s Lucid Psycheceuticals click here  NexTech AR Solutions at frontier of growth as it shifts towards self-service SaaS model click here Revive Therapeutics added to AdvisorShares Psychedelics ETF click here HealthLynked says subsidiary will...

Continue reading

West Mining Commences Drilling on The Kena Copper Zone, Kena Property, BC

VANCOUVER, British Columbia, Sept. 21, 2021 (GLOBE NEWSWIRE) — West Mining Corp. (“West” or the “Company”) (CSE: WEST) (OTC: WESMF) has now commenced the 2021 diamond drilling program on the Kena Copper Zone area of its 100% owned Kena gold and copper project in southeastern British Columbia.  A total of 4000 metres of diamond drilling is planned. The over 8500 hectare Kena Project, consists of the Kena, Daylight and Athabasca Properties which trend along a 20 kilometre long favourable mineralized belt. “The Company is very pleased to see the drill crew mobilized and work commenced on the copper zone at the Kena Property,” stated Nicholas Houghton, President and CEO. The Kena Copper Zone is identified by a significant copper geochemical anomaly associated with a zone of high chargeability, lying within mafic volcanic and subvolcanic...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.